Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -16.43% vs 9.78% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -51.15% vs 49.59% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -36.78% vs 42.81% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -35.08% vs -60.10% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Sichuan Kelun Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.65% vs -12.50% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -16.43% vs 9.78% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -31.12% vs 49.60% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -51.15% vs 49.59% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -11.65% vs 26.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -36.78% vs 42.81% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.64% vs -5.36% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -35.08% vs -60.10% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






